solomo.ai

India Glycols Ltd (INDIAGLYCO) — shareholding pattern, promoter holding, financials and share price

About India Glycols Ltd (INDIAGLYCO)

India Glycols Ltd operates in the Breweries & Distilleries industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as INDIAGLYCO and on the BSE under scrip code 500201. Its ISIN is INE560A01023.

Established in 1988, India Glycols Ltd. is engaged in the manufacturing of green technology-based bulk, specialty & performance chemicals, and natural gums, spirits, industrial gases, sugar, and nutraceuticals. [1] [2]

India Glycols Limited (IGL) is an integrated bio-based chemicals and consumer alcohol manufacturer with businesses in Bio-based Specialties & Performance Chemicals (BSPC), Bio-Fuel (ethanol/ENA), Potable Spirits (IMFL and country liquor) and Ennature Biopharma (plant-based APIs and nutraceuticals), operating three major manufacturing hubs at Kashipur, Gorakhpur and Dehradun with global exports and multiple strategic JVs.

Q3FY26 and 9MFY26 delivered record net turnover and EBITDA for India Glycols, with 9M revenue rising 11.4% and EBITDA up 28.9% (EBITDA margin 15.0%), and Q3 revenue up 13% with EBITDA up 36.1% as management cites realization of operational actions and high‑margin mix shift driving margin expansion across BSPC and Biofuel segments.

Listed peers in Breweries & Distilleries: Tilaknagar Industries Ltd, Piccadily Agro Industries Ltd, Globus Spirits Ltd, G M Breweries Ltd, Associated Alcohols & Breweries Ltd, Som Distilleries & Breweries Ltd.

Valuation & Returns

10 Jul 2026

At ₹1,069.35 a share on 10 Jul 2026, India Glycols Ltd (INDIAGLYCO) was valued at a price-to-earnings ratio of 24.48x against an industry P/E of 54.25x and a price-to-book of 3.18x on a book value of ₹336.56 per share as of Mar 2025. Solomo computes return on equity of 12.98% and return on capital employed of 13.13% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
24.48x
Industry P/E
54.25x
P/B
3.18x
EPS (TTM)
₹43.68
Book value / share
₹336.56
ROE
12.98%
ROCE
13.13%
ROA
4.74%
Debt / equity
0.84x
Dividend yield
1.17%
EBITDA margin
7.12%
52-week range
₹793.95 – ₹1,222.85

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, India Glycols Ltd (INDIAGLYCO) reported revenue of ₹4,211 crore, net profit of ₹293 crore and earnings per share of ₹43.68. That compares with revenue of ₹3,768 crore and net profit of ₹231 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹976 crore and net profit ₹87 crore (consolidated).

Consolidated annual results for India Glycols Ltd (INDIAGLYCO), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)2,8682,6513,2943,7684,211
Net profit (₹ cr)340141173231293
EPS (₹)54.920.2127.9537.3143.68
Compound annual growth for India Glycols Ltd (INDIAGLYCO). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth11.94%11.71%11.07%14.40%
Profit growth-15.32%-13.13%33.49%
Stock price CAGR37%26%56%16%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 59.63% of India Glycols Ltd (INDIAGLYCO) (unchanged from the previous quarter), foreign institutional investors (FII) hold 2.24% and domestic institutional investors (DII) hold 5.22%. Market capitalisation was ₹7,168 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2001.

Largest disclosed public shareholders in Jun 2026: PUNEET BHATIA 1.77%, 360 One Pipe Fund 1.69%, Investor Education and Protection Fund 1.4%, HUF 1.11%, Negen Undiscovered Value Fund 1.04%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202659.63%-2.24%5.22%40.37%
Mar 202659.63%-2.27%5.2%40.37%
Dec 202559.63%-2.42%5.23%40.37%
Sep 202561.01%-2.62%1.33%38.99%
Jun 202561.01%-3.44%1.39%38.99%
Mar 202561.01%-2.25%0.91%38.99%
Dec 202461.01%-2.44%2%38.99%
Sep 202461.01%-2.9%1.94%38.99%
Every quarter since Jun 2001 Filing data, not investment advice.